X
AMED

Xponance’s Amedisys AMED Stock Holding History

Xponance’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,663
Closed -$360K – 1531
2025
Q2 		$360K Sell
3,663
-72
-2% -$6.81K ﹤0.01% 1068
2025
Q1 		$346K Sell
3,735
-614
-14% -$56.6K ﹤0.01% 1049
2024
Q4 		$395K Buy
4,349
+148
+4% +$13.6K ﹤0.01% 1027
2024
Q3 		$405K Buy
4,201
+49
+1% +$4.78K ﹤0.01% 1003
2024
Q2 		$381K Sell
4,152
-988
-19% -$91.7K ﹤0.01% 984
2024
Q1 		$474K Buy
5,140
+686
+15% +$64.3K 0.01% 956
2023
Q4 		$423K Buy
4,454
+378
+9% +$35.3K 0.01% 986
2023
Q3 		$381K Buy
4,076
+125
+3% +$11.6K 0.01% 979
2023
Q2 		$361K Sell
3,951
-349
-8% -$28.6K ﹤0.01% 999
2023
Q1 		$316K Buy
4,300
+43
+1% +$3.72K ﹤0.01% 1031
2022
Q4 		$356K Buy
4,257
+448
+12% +$40.4K 0.01% 1000
2022
Q3 		$369K Sell
3,809
-68
-2% -$8.11K 0.01% 941
2022
Q2 		$408K Sell
3,877
-2,593
-40% -$331K 0.01% 935
2022
Q1 		$1.11M Sell
6,470
-25
-0.4% -$3.73K 0.02% 553
2021
Q4 		$1.05M Sell
6,495
-86
-1% -$13.8K 0.02% 587
2021
Q3 		$981K Sell
6,581
-95
-1% -$19.7K 0.02% 566
2021
Q2 		$1.64M Sell
6,676
-71
-1% -$18.6K 0.03% 413
2021
Q1 		$1.79M Hold
6,747
– – 0.04% 339
2020
Q4 		$1.98M Buy
6,747
+32
+0.5% +$8.21K 0.04% 320
2020
Q3 		$1.59M Buy
6,715
+537
+9% +$122K 0.04% 328
2020
Q2 		$1.23M Buy
+6,178
New +$1.15M 0.03% 346

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Xponance's AMED Position: Q3 2025 in Review

Xponance sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,663 shares — an estimated $360K sold.

Xponance first reported a position in AMED in Q2 2020 and held it in 21 quarters. The position peaked at $1.98M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Xponance reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Xponance sold 3,663 Amedisys shares in Q3 2025, an estimated $360K.
  • Xponance first reported a position in Amedisys in Q2 2020 and held it in 21 quarters.
  • Xponance's Amedisys position peaked at $1.98M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Xponance's 13F filing for Q3 2025, filed 12 Nov 2025.